CARDIVA MEDICAL, INC.
1615 Wyatt Drive
Santa Clara, CA 95054
February 26, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: J. Nolan McWilliams
Justin Dobbie
Tracey Houser
Brian Cascio
RE: Cardiva Medical, Inc.
Withdrawal of Registration Statement on Form S-1
File No. 333-251885
Ladies and Gentlemen:
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Cardiva Medical, Inc. (the “Registrant”) hereby respectfully requests that the U.S. Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof, of the Registrant’s Registration Statement on Form S-1 (File No. 333-251885) together with all exhibits and amendments thereto (collectively, the “Registration Statement”) initially filed with the Commission on January 4, 2021.
The Registrant has determined not to pursue the public offering to which the Registration Statement relates at this time. The Registration Statement has not been declared effective by the Commission and the Registrant confirms that no securities have been sold pursuant to the Registration Statement. Accordingly, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477.
The Company acknowledges that no refund will be made for fees paid to the Commission in connection with the filing of the Registration Statement. However, the Company requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use should the Company proceed with the filing of a subsequent registration statement meeting the requirements of Rule 457(p) promulgated under the Securities Act.
Should you have any questions regarding this request, please do not hesitate to contact counsel to the Registrant, Mark Weeks of Cooley LLP at (650) 843-5011, or in his absence, Josh Seidenfeld at (650) 843-5862.
Sincerely, | ||
Cardiva Medical, Inc. | ||
By: | /s/ John Russell | |
Name: John Russell | ||
Title: Chief Executive Officer |
cc: Lisa Garrett, Cardiva Medical, Inc.
Mark Weeks, Cooley LLP
Josh Seidenfeld, Cooley LLP
Milson Yu, Cooley LLP